Načítá se...
LINACLOTIDE – A SECRETAGOGUE AND ANTI-HYPERALGESIC AGENT – WHAT NEXT?
Ongoing clinical trials suggest that linaclotide, a first in class, 14-amino acid peptide guanylate cyclase-C (GC-C) receptor agonist and intestinal secretagogue is an effective treatment for chronic constipation. A study in this issue of the Journal suggests that linaclotide also has anti-hyperalge...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3059226/ https://ncbi.nlm.nih.gov/pubmed/20377786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2982.2009.01465.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|